Physician-Led Switching From Reference Biologics to Biosimilars: What Is the Effect on Selected Health-Related Outcomes and Costs for Patients With Inflammatory Bowel Disease in Germany?

Value in Health · Elsevier

Аннотация

Publication date: November 2026 Source: Value in Health, Volume 29, Issue 11 Author(s): Isa Maria Steiner, Benjamin Birkner, Mateo Wittig Martinez, Tom Stargardt

Читать у издателя →

Похожие статьи